D-0916-2018 Class II Terminated
FDA drug recall D-0916-2018 was initiated by Akorn, Inc. on Jun 22, 2018 and is designated Class II. Reason for recall: CGMP Deviations The recall status is terminated (terminated Nov 6, 2020). Affected quantity: 89,507 vials.
Recall Details
- Product Type
- Drugs
- Report Date
- Jul 18, 2018
- Initiation Date
- Jun 22, 2018
- Termination Date
- Nov 6, 2020
- Product Quantity
- 89,507 vials
Product Description
Acetylcysteine for Injection 6 g/30 mL (200 mg/mL). Rx Only. Manufactured by Akron Inc., Lake Forest, IL 60045. NDC 17478-660-30.
Reason for Recall
CGMP Deviations
Distribution Pattern
U.S. Nationwide
Code Information
Lots: 061496A, Exp. 06/2018; 111696A, Exp. 11/2018; 061947A, Exp. 06/2019; 091267A, Exp. 09/2019
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0916-2018
- openFDA file date
- Oct 23, 2026
- Loaded by RegDataLab
- Oct 26, 2026